These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25294795)

  • 1. Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment.
    Regnault H; Bourrier A; Lalande V; Nion-Larmurier I; Sokol H; Seksik P; Barbut F; Cosnes J; Beaugerie L
    Dig Liver Dis; 2014 Dec; 46(12):1086-92. PubMed ID: 25294795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study.
    Sokol H; Lalande V; Landman C; Bourrier A; Nion-Larmurier I; Rajca S; Kirchgesner J; Seksik P; Cosnes J; Barbut F; Beaugerie L
    Dig Liver Dis; 2017 Jun; 49(6):643-646. PubMed ID: 28215602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk factors of Clostridium difficile infection in patients with inflammatory bowel disease.
    Stoica O; Trifan A; Cojocariu C; Gîrleanu I; Maxim R; Stanciu MC
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):81-6. PubMed ID: 25970947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center.
    Ott C; Girlich C; Klebl F; Plentz A; Iesalnieks I; Schölmerich J; Obermeier F
    Digestion; 2011; 84(3):187-92. PubMed ID: 21646782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Clostridium difficile on inflammatory bowel disease.
    Issa M; Vijayapal A; Graham MB; Beaulieu DB; Otterson MF; Lundeen S; Skaros S; Weber LR; Komorowski RA; Knox JF; Emmons J; Bajaj JS; Binion DG
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):345-51. PubMed ID: 17368234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease.
    Ananthakrishnan AN; McGinley EL; Binion DG
    Gut; 2008 Feb; 57(2):205-10. PubMed ID: 17905821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases.
    Ricciardi R; Ogilvie JW; Roberts PL; Marcello PW; Concannon TW; Baxter NN
    Dis Colon Rectum; 2009 Jan; 52(1):40-5. PubMed ID: 19273954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Clostridium difficile infection in inflammatory bowel disease.
    Rodemann JF; Dubberke ER; Reske KA; Seo DH; Stone CD
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):339-44. PubMed ID: 17368233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection.
    Ben-Horin S; Margalit M; Bossuyt P; Maul J; Shapira Y; Bojic D; Chermesh I; Al-Rifai A; Schoepfer A; Bosani M; Allez M; Lakatos PL; Bossa F; Eser A; Stefanelli T; Carbonnel F; Katsanos K; Checchin D; de Miera IS; Reinisch W; Chowers Y; Moran GW;
    J Crohns Colitis; 2010 Jun; 4(2):194-8. PubMed ID: 21122505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients.
    Nguyen GC; Kaplan GG; Harris ML; Brant SR
    Am J Gastroenterol; 2008 Jun; 103(6):1443-50. PubMed ID: 18513271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile infection and inflammatory bowel disease.
    Cojocariu C; Stanciu C; Stoica O; Singeap AM; Sfarti C; Girleanu I; Trifan A
    Turk J Gastroenterol; 2014 Dec; 25(6):603-10. PubMed ID: 25599768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interleukin-4 polymorphism is associated with susceptibility to Clostridium difficile infection in patients with inflammatory bowel disease: results of a retrospective cohort study.
    Connelly TM; Koltun WA; Sangster W; Berg AS; Hegarty JP; Harris L; Deiling S; Stewart DB
    Surgery; 2014 Oct; 156(4):769-74. PubMed ID: 25239315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
    Micic D; Yarur A; Gonsalves A; Rao VL; Broadaway S; Cohen R; Dalal S; Gaetano JN; Glick LR; Hirsch A; Pekow J; Sakuraba A; Walk ST; Rubin DT
    Dig Dis Sci; 2018 Apr; 63(4):1016-1024. PubMed ID: 29417331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.
    Clayton EM; Rea MC; Shanahan F; Quigley EM; Kiely B; Hill C; Ross RP
    Am J Gastroenterol; 2009 May; 104(5):1162-9. PubMed ID: 19319128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
    Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J
    Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection.
    Ben-Horin S; Margalit M; Bossuyt P; Maul J; Shapira Y; Bojic D; Chermesh I; Al-Rifai A; Schoepfer A; Bosani M; Allez M; Lakatos PL; Bossa F; Eser A; Stefanelli T; Carbonnel F; Katsanos K; Checchin D; Miera IS; Chowers Y; Moran GW;
    Clin Gastroenterol Hepatol; 2009 Sep; 7(9):981-7. PubMed ID: 19523534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile infection and inflammatory bowel disease.
    Reddy SS; Brandt LJ
    J Clin Gastroenterol; 2013 Sep; 47(8):666-71. PubMed ID: 23507767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study.
    Barbut F; Corthier G; Charpak Y; Cerf M; Monteil H; Fosse T; Trévoux A; De Barbeyrac B; Boussougant Y; Tigaud S; Tytgat F; Sédallian A; Duborgel S; Collignon A; Le Guern ME; Bernasconi P; Petit JC
    Arch Intern Med; 1996 Jul; 156(13):1449-54. PubMed ID: 8678714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Clostridium difficile infection in children with inflammatory bowel disease compared to oncology and immunocompetent patients.
    Hojsak I; Ferenc T; Bojanić K; Mišak Z; Močić Pavić A; Lukić-Grlić A; Kolaček S
    Digestion; 2012; 86(1):6-11. PubMed ID: 22688504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence and outcomes from Clostridium difficile infection in hospitalized adults with inflammatory bowel disease.
    Saffouri G; Gupta A; Loftus EV; Baddour LM; Pardi DS; Khanna S
    Scand J Gastroenterol; 2017 Nov; 52(11):1240-1247. PubMed ID: 28782372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.